Institut Curie and Affymetrix, Li-Cor, UBS Warburg and Affymetrix, GeneGo and GlaxoSmithKline, Sorensen Genomics and Pacific Rim Consulting, and Lynx, USC and Solexa | GenomeWeb

Institut Curie to Use Affy Arrays to Develop Cancer Diagnostics

The Institut Curie of France will use Affymetrix microarrays in several large-scale clinical studies aimed at developing diagnostic tests for cancer, the two partners said this week.

Institut Curie, a private cancer research center based in Paris, plans several translational medicine studies, based on its library of frozen tumor samples, which will use Affymetrix’s GeneChip arrays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.